Navigation Links
EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients with Hypertension
Date:2/6/2012

barrier and appear in cord blood and may be associated with adverse reactions, including fetal or neonatal jaundice and thrombocytopenia.

In patients with an activated renin-angiotensin-aldosterone system (RAAS), such as volume- and/or salt-depleted patients, EDARBI and EDARBYCLOR can cause excessive hypotension. Correct volume or salt depletion prior to administration of EDARBI or EDARBYCLOR.

Patients with renal impairment should be monitored for worsening renal function. In patients whose renal function may depend on the activity of the renin-angiotensin system, treatment with ACE inhibitors and ARBs has been associated with oliguria or progressive azotemia and rarely with acute renal failure and death. In patients with renal artery stenosis, EDARBI and EDARBYCLOR may cause renal failure. In patients with renal disease, chlorthalidone may precipitate azotemia. Consider withholding or discontinuing EDARBI or EDARBYCLOR if progressive renal impairment becomes evident.

Hypokalemia is a dose-dependent adverse reaction that may develop with chlorthalidone. Coadministration of digitalis may exacerbate the adverse effects of hypokalemia. EDARBYCLOR attenuates chlorthalidone-associated hypokalemia.

Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving chlorthalidone or other thiazide diuretics.

The most common adverse reaction that occurred more frequently with EDARBI than placebo in adults was diarrhea (2 percent versus 0.5 percent). The adverse reactions that occurred at an incidence of greater than or equal to 2 percent of EDARBYCLOR-treated patients, and greater than azilsartan medoxomil or chlorthalidone, were dizziness (8.9 percent) and fatigue (2.0 percent). The incidence of consecutive elevations of creatinine with EDARBYCLOR (greater than or equal to 50 percent from baseline and greater than the upper limit of normal) was 2 percent; elevations were typically transient, or nonprogressive and reve
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
2. EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension
3. FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
4. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
5. New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
6. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
7. NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription
8. PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
9. Nearly 9 Million Kaiser Permanente Health Records Securely Available on Mobile Devices
10. Edgemont - New Fluoxetine Tablets, 60 mg Now Available
11. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... Calif. , May 21, 2015  Cardica, Inc. (Nasdaq: ... new employee Greg Watson , the company,s vice president ... of the company,s common stock, at a per share exercise ... 2015. The stock option was granted pursuant to Cardica, Inc.,s ... directors in May 2015 under Rule 5653(c)(4) of the Nasdaq ...
(Date:5/21/2015)... England , May 21, 2015 ... Bekämpfung von Arzneimittelfälschungen - Zwecks Leistungsvergleich ... Arzneimittelprüfdienstes wird auf EG-Mitgliedstaaten verwiesen, in ... betrieben werden.  Wählen Sie ein Aegate-Land: ... der Richtlinie zur Bekämpfung von Arzneimittelfälschungen ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... Corporate Affairs – also called Public Affairs ... key success drivers for organizations. In many organizations, ... Government Affairs, Corporate Communications and Patient Advocacy – ... interactions with important external and internal partners. ...
... Nov. 5, 2010 Will power wheelchairs continue ... of federal regulatory and policy changes? There are ... providers in Nevada that the changes in Medicare policies may ... and services to beneficiaries. One of the ...
Cached Medicine Technology:Corporate Affairs Role in Internal and External Relationships Key to Organizational Success 2Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs 2Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs 3Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs 4
(Date:5/22/2015)... 22, 2015 Gateway Building Concepts is ... The services the company specialize in include decks, additions, ... pool houses and much more. , The redesigned ... owner of the company. It includes two geometrical lines ... was thought out to be used with many things ...
(Date:5/22/2015)... A Phase 3 French study, ... of Clinical Oncology (ASCO)’s annual meeting at the ... those patients who received bevacizumab in addition to ... (Avastin® Genentech, Inc.) is an antibody that blocks ... routinely used to treat many other cancers, including ...
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... Bay Lightning vs. New York Rangers NHL Eastern Conference Finals ... finals is together unless specified otherwise in the ticket listing. ... New York Rangers are at the top of the Eastern ... League has had its share of ups and downs over ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 In April ... In the past 9 years they have concentrated their ... United States and Canada. Because of this growth and ... established corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, ... specializes in opening new dental offices, dental start ups, ...
(Date:5/22/2015)... Bryce Henson, local fitness icon and owner of ... accepted his program’s 100th client. Henson says that reaching ... location evidences the powerful impact his boot camp is ... Camp is the nation’s most popular and fastest growing ... across North America, Europe and Australia. Anaheim Fit Body ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2
... of Health has announced that the Salk Institute will receive ... research center intended to accelerate brain research that lays the ... and neurological diseases. The new center is one of ... Neurological Disorders and Stroke to focus on basic brain research. ...
... N.Y., CAMBRIDGE, M.A. and SHENZHEN, CHINA (October 13, 2011) ... advocacy organization, and BGI, the largest genomic organization in ... sequencing, jointly announce their partnership to create the world,s ... spectrum disorders (ASD). Using the Autism Speaks Autism Genetic ...
... their own previous world-best efforts to pluck out just the ... core of multiple sclerosis and a large number of rare, ... directed stem cells from the human brain to become oligodendrocytes ... crucial fatty material that coats neurons and allows them to ...
... -- Women throughout the world will benefit from a ... aims to change the way in which ovarian cancer ... Partnership Against Cancer are providing a total of $5-million ... Program called COEUR. The program will identify new biomarkers ...
... (HealthDay News) -- The percentage of children with asthma in ... nearly doubled since the late 1990s, a new federal government ... Expenditure Panel Survey showed that the use of controller drugs ... 58 percent in 2007-2008, according to the latest News ...
... disparities between Latinos and non-Latino whites, mostly from a policy ... perspective of the patient, in terms of access, use and ... how do the physicians feel about the quality of care ... patients, compared with physicians whose patients are primarily white and ...
Cached Medicine News:Health News:Salk to accelerate brain research with $4.5 million NIH grant 2Health News:Autism Speaks and BGI to complete whole genome sequencing on 10,000 with autism 2Health News:Precision with stem cells a step forward for treating MS, other diseases 2Health News:Precision with stem cells a step forward for treating MS, other diseases 3Health News:Terry Fox Research Institute aims to change diagnosis and management of ovarian cancer worldwide 2Health News:Terry Fox Research Institute aims to change diagnosis and management of ovarian cancer worldwide 3Health News:Use of Asthma Controller Meds on the Rise Among U.S. Kids 2Health News:Physicians treating Latinos have high hurdles to jump, study shows 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: